3.9 | | Wnt8a | 'stabilization-competent' vs 'stabilization-incompetent' in '23 day; secondary reprogramming cell' | age, cell type, phenotype | Transcription profiling by high throughput sequencing in gene expresion profile of 4 SC clones and 4 SI clones at different time points defined a stabilization competency signiture |
3.5 | | Wnt8a | 'Mettl6 knockout clone D1' vs 'wild type genotype' | genotype | METTL6 is a tRNA m3C methyltransferase that regulates translation and tumor cell proliferation |
2.8 | | Wnt8a | 'Mettl6 knockout clone G6' vs 'wild type genotype' | genotype | METTL6 is a tRNA m3C methyltransferase that regulates translation and tumor cell proliferation |
-2.8 | | Wnt8a | 'flusilazole; 10 micromolar' vs 'none' at '4-day differentiated' | compound, sampling time point | Transcriptional profiling by array of mouse embryonic stem cells treated with six different compounds |
-2.3 | | Wnt8a | 'pabpn1l -/-' vs 'wild type genotype' in 'zygote' | genotype, organism part | RNA-seq of oocytes and zygotes from pabpn1l ko and wt female mice |
2.2 | | Wnt8a | 'stabilization-competent' vs 'stabilization-incompetent' in '22 day; secondary reprogramming cell' | age, cell type, phenotype | Transcription profiling by high throughput sequencing in gene expresion profile of 4 SC clones and 4 SI clones at different time points defined a stabilization competency signiture |
-2 | | Wnt8a | 'hexaconazole; 25 micromolar' vs 'none' at '4 day' | compound, time | Transcription profiling by array of mouse embryonic multipotent stem cells treated with valproic acid, cyproconazole and hexaconazole |
2 | | Wnt8a | 'p150 subunit of CAF-1 siRNA knockdown' vs 'scrambled siRNA' | RNA interference | RNA-seq of control siRNA, p150 siRNA and p60 siRNA transfected mES cells |
-1.8 | | Wnt8a | '19BL; undifferentiated 3factor-reprogrammed induced pluripotent stem cell' vs 'R1; undifferentiated embryonic stem cell' at '0 day' | cell line, growth condition, time | Natural cardiogenesis-based template predicts cardiogenic potential of induced pluripotent stem cell lines |
-1.7 | | Wnt8a | 'cyproconazole; 100 micromolar' vs 'none' at '4 day' | compound, time | Transcription profiling by array of mouse embryonic multipotent stem cells treated with valproic acid, cyproconazole and hexaconazole |
1.7 | | Wnt8a | '3 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
1.3 | | Wnt8a | '2 day' vs '0 day' | age | Transcription profiling of mouse embyronic stem cell line CGR8 during the first 10 days of differentiation into embryoid bodies |
-1.3 | | Wnt8a | 'cyproconazole; 25 micromolar' vs 'none' at '4 day' | compound, time | Transcription profiling by array of mouse embryonic multipotent stem cells treated with valproic acid, cyproconazole and hexaconazole |
-1.3 | | Wnt8a | 'hexaconazole; 6 micromolar' vs 'none' at '4 day' | compound, time | Transcription profiling by array of mouse embryonic multipotent stem cells treated with valproic acid, cyproconazole and hexaconazole |
1.3 | | Wnt8a | 'lung carcinoma' vs 'normal' in 'CD11b+Ly6G+ neutrophil' | cell type, disease | Transcriptome analysis of isolated stormal cells and tumor epithelial cells in mouse lung cancer by RNA-Seq |
1.2 | | Wnt8a | '12 nanomolar; retinoic acid' vs 'none' at '24 hour' | compound, time | Transcription profiling by array of mouse embryonic stem cells after treatment with 5-fluourouracil, methoxyacetic acid, monobutl phthalate, Penicillin G, retinoic acid or valproic acid |
1.2 | | Wnt8a | 'Sall4 homozygous knockout' vs 'wild type genotype' | genotype | RNA-Seq of Sall4 mutants in mouse embryonic stem cells |
-1.2 | | Wnt8a | 'Pcl2 knockdown' vs 'control' | genotype | Gene expression profile in mouse embryonic stem cells in which endogenous Pcl2 expression was stably knocked down using short hairpin RNA |
1.2 | | Wnt8a | 'tumor' vs 'normal' in 'kidney' | clinical information, organism part | Premature termination of in vivo reprogramming leads to cancer development through altered epigenetic regulation [array] |
1.1 | | Wnt8a | 'Setd5 homozygous (null) knockout' vs 'Setd5 heterozygous knockout' | genotype | Transcriptional profiling of Setd5 heterozygous and knockout mouse embryonic stem cells |
-1.1 | | Wnt8a | 'R1_Pax4+' at '0 day' vs 'wild type' at '0 day' | phenotype, time | Transcription profiling of mouse wild type R1 and cells expressing Pax4 following induction of pacreatic differentitation |
-1 | | Wnt8a | 'cyproconazole; 6 micromolar' vs 'none' at '4 day' | compound, time | Transcription profiling by array of mouse embryonic multipotent stem cells treated with valproic acid, cyproconazole and hexaconazole |
1 | | Wnt8a | 'Panct1' vs 'non-targeting siRNA' | RNA interference | A combined RNAi and localization approach for dissecting long noncoding RNAs reveals a function of Panct1 in ES cells |
1 | | Wnt8a | 'BIO' vs 'none' at '6 day' | age, compound | Transcription profiling of mouse embryonic stem cell line CGR8 during differentiation to mesenchymal stem cells and then adipocyte precursors |
-1 | | Wnt8a | 'induced neuronal cell' vs 'pluripotent embryonic stem cell' | phenotype | Transcription profiling by high throughput sequencing of retinoic acid-differentiated neuronal cells compared to nondifferentiated pluripotent embryonic stem cells |
1 | | Wnt8a | 'CD2314 and BIO' vs 'none' at '6 day' | age, compound | Transcription profiling of mouse embryonic stem cell line CGR8 during differentiation to mesenchymal stem cells and then adipocyte precursors |
1 | | Wnt8a | 'Notch 1 and 2 null' vs 'wild type' | genotype | Quantitative Analysis of Notch mutant (Notch1&2-null, Psen1&2-null, RBPjk-null) and wild-type hair follicle transcriptomes by NGS |